Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-15-024867
Filing Date
2015-08-13
Accepted
2015-08-13 16:09:45
Documents
1
Period of Report
2015-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 5030
  Complete submission text file 0001127602-15-024867.txt   6470
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Issuer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 251 BALLARDVALE STREET WILMINGTON MA 01887
Business Address
Smith David Ross (Reporting) CIK: 0001650274 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15943 | Film No.: 151050770